Financials Reliq Health Technologies Inc.

Equities

RHT

CA75955T1030

Software

Delayed Toronto S.E. 03:59:56 2024-01-16 pm EST 5-day change 1st Jan Change
0.215 CAD -.--% Intraday chart for Reliq Health Technologies Inc. -.--% -6.52%

Valuation

Fiscal Period: June 2017 2018 2019 2020 2021 2022
Capitalization 1 9.136 211.3 32.71 38.44 83.13 89.58
Enterprise Value (EV) 1 8.632 201.4 32.24 38.76 83.21 89.65
P/E ratio -2.92 x -12.9 x -2.37 x -3.28 x -6.5 x -10.6 x
Yield - - - - - -
Capitalization / Revenue 50 x 93.1 x 180 x 33.6 x 56.9 x 10.5 x
EV / Revenue 47.3 x 88.7 x 177 x 33.9 x 56.9 x 10.5 x
EV / EBITDA -3.16 x -14.8 x -2.53 x -3.58 x -7.2 x -11.1 x
EV / FCF -4.75 x -67.5 x -7.77 x -9.64 x -32.3 x -47.5 x
FCF Yield -21% -1.48% -12.9% -10.4% -3.1% -2.1%
Price to Book 486 x 17.9 x 12.3 x 38.4 x 83.9 x 14.1 x
Nbr of stocks (in thousands) 76,135 113,619 125,806 142,365 171,402 188,581
Reference price 2 0.1200 1.860 0.2600 0.2700 0.4850 0.4750
Announcement Date 10/30/17 10/29/18 10/28/19 10/28/20 10/28/21 11/2/22
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2017 2018 2019 2020 2021 2022
Net sales 1 0.1827 2.269 0.1819 1.143 1.462 8.552
EBITDA 1 -2.735 -13.63 -12.74 -10.82 -11.56 -8.106
EBIT 1 -2.737 -13.63 -13.38 -11.16 -11.56 -8.221
Operating Margin -1,498.38% -600.72% -7,352.78% -975.99% -790.41% -96.14%
Earnings before Tax (EBT) 1 -2.461 -13.8 -13 -11.12 -11.78 -8.171
Net income 1 -2.461 -13.8 -13 -11.12 -11.78 -8.171
Net margin -1,347.44% -607.92% -7,148.79% -973.06% -805.69% -95.55%
EPS 2 -0.0411 -0.1446 -0.1098 -0.0823 -0.0746 -0.0446
Free Cash Flow 1 -1.816 -2.984 -4.148 -4.021 -2.578 -1.887
FCF margin -994.26% -131.51% -2,280.42% -351.76% -176.3% -22.07%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 10/30/17 10/29/18 10/28/19 10/28/20 10/28/21 11/2/22
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2023 Q3
Net sales -
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 0.731
Net margin -
EPS 2 0.004000
Dividend per Share -
Announcement Date 5/30/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - 0.32 0.08 0.07
Net Cash position 1 0.5 9.92 0.47 - - -
Leverage (Debt/EBITDA) - - - -0.03 x -0.006615 x -0.00891 x
Free Cash Flow 1 -1.82 -2.98 -4.15 -4.02 -2.58 -1.89
ROE (net income / shareholders' equity) 1,430% -233% -179% -583% -1,175% -222%
ROA (Net income/ Total Assets) -218% -130% -104% -216% -234% -74.9%
Assets 1 1.128 10.58 12.54 5.158 5.027 10.92
Book Value Per Share 2 0 0.1000 0.0200 0.0100 0.0100 0.0300
Cash Flow per Share 2 0.0100 0.0900 0 0 0 0
Capex - - - 0.05 - -
Capex / Sales - - - 4.39% - -
Announcement Date 10/30/17 10/29/18 10/28/19 10/28/20 10/28/21 11/2/22
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RHT Stock
  4. Financials Reliq Health Technologies Inc.